| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.447 | 30.010 | 40.312 | 46.092 | 36.390 | 45.206 |
| Total Income - EUR | - | - | - | - | 5.447 | 32.717 | 44.792 | 50.205 | 41.197 | 49.275 |
| Total Expenses - EUR | - | - | - | - | 6.171 | 35.830 | 41.752 | 46.472 | 40.347 | 43.453 |
| Gross Profit/Loss - EUR | - | - | - | - | -724 | -3.114 | 3.040 | 3.733 | 851 | 5.823 |
| Net Profit/Loss - EUR | - | - | - | - | -888 | -3.298 | 2.718 | 3.281 | 677 | 4.669 |
| Employees | - | - | - | - | 0 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Dermazone Inc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 32.111 | 27.140 | 22.937 | 18.618 | 14.271 |
| Current Assets | - | - | - | - | 34.179 | 8.133 | 10.662 | 6.313 | 7.529 | 11.774 |
| Inventories | - | - | - | - | 0 | 6.152 | 7.419 | 938 | 3.536 | 2.018 |
| Receivables | - | - | - | - | 8.456 | 0 | 1.226 | 0 | 196 | 313 |
| Cash | - | - | - | - | 25.723 | 1.980 | 2.016 | 5.375 | 3.797 | 9.443 |
| Shareholders Funds | - | - | - | - | -845 | -4.128 | -1.318 | 1.958 | 2.630 | 7.284 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.345 | 13.901 | 13.362 | 5.522 | 6.183 | 5.342 |
| Income in Advance | - | - | - | - | 33.823 | 30.493 | 25.761 | 21.772 | 17.650 | 13.518 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermazone Inc S.r.l.